Mutation Information
Mutation Site
|
C69* |
Mutation Type
|
Amino acid level |
Gene/Protein/Region Type
|
S |
Combined Mutation
|
s.C69*+rt.S78T;rt.M204I+s.C69*+rt.S78T;rt.M204I+rt.L180M+s.C69*+rt.S78T;rt.M204V+rt.M204I+rt.L180M+s.C69*+rt.S78T;rt.M204V+rt.L180M+s.C69*+rt.S78T;rt.A181T+rt.N236T+s.C69*+rt.S78T;rt.A181T+rt.N236T+rt.A181V+s.C69*+rt.S78T;rt.A181T+rt.A181V+s.C69*+rt.S78T;rt.M204V+rt.M204I+rt.T184A+rt.L180M+s.C69*+rt.S78T;rt.M204V+rt.T184A+rt.L180M+s.C69*+rt.S78T;rt.M250L+rt.M204V+rt.M204I+s.C69*+rt.S78T;rt.N236T+rt.M204V+rt.A181T+rt.L180M+s.C69*+rt.S78T;rt.M204I+rt.S202G+s.C69*+rt.S78T |
Relevant Drug
|
lamivudine (LAM);adefovir (ADV);entecavir (ETV);tenofovir (TDF) |
Country
|
China |
Literature Information
PubMed PMID
|
31398372
|
Disease
|
Chronic hepatitis B
|
Published Year
|
2019 |
Journal
|
Antiviral research |
Title
|
Investigation of hepatitis B virus (HBV) rtS78T/sC69* mutation in a large cohort of chronic HBV-infected patients with nucleoside/nucleotide analogue treatment. |
Author
|
Luo D,Liu Y,Chen R,Niu M,Liu L,Li X,Li Q,Huang B,Wang J,Xu D,Lin S |
Evidence
|
Investigation of hepatitis B virus (HBV) rtS78T/sC69* mutation in a large cohort of chronic HBV-infected patients with nucleoside/nucleotide analogue treatment.
|
|
|